Showing 2 posts of 2 posts found.
Roche will pay $450 million to acquire the RNA specialist firm Santaris Pharma in order to once again begin research …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement